Isotechnika Pharma Inc IPHAF

RE: RE: REITERATE DMC REPORTS

[labumba]

" Surely you don't think that the European trial results, even if positive, are going to take ISA's share price higher? "

Surely, if the European tial results turn out to be positive, the share price will be on a high level....I think it will be a buyout to follow but not at this price......the Canadian trial and the 4 DMC reports shows a vote of confidence.

I bet the Voclo has better SeCr and GFR readings verus Cyclosoporin after 60 weeks and that will settle the future of this drug one for all